Standardized senna in the management of constipation in the puerperium: A clinical trial.
Successful treatment of constipation in the immediate postpartum period in 93% of White patients and 96% of Coloured patients was achieved in a clinical trial of standardized senna tablets (Senokot; Reckitt & Colman). This is significantly better than the success rates of 51% and 59% achieved in White and Coloured controls treated with a placebo. Minor abdominal cramps occurred in some 13% of the patients treated with standardized senna, and in 4% of the controls given the placebo. There is no evidence to suggest that standardized senna has any effect whatsoever on a breast-fed baby if taken by the mother.
D000328:Adult; D001942:Breast Feeding; D002986:Clinical Trials as Topic; D003248:Constipation / Q000188:drug therapy*; D003968:Diarrhea, Infantile / Q000139:chemically induced; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D011247:Pregnancy; D011644:Puerperal Disorders / Q000188:drug therapy*; D012676:Senna Extract / Q000009:adverse effects / Q000627:therapeutic use*
D012676:Senna Extract